Covered recipient · General Payments record
OBIAGELI U OGBATA
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2019–2025
$25,550.84
- Reported across 111 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,977.00 | 1 |
| Food and Beverage | $1,046.81 | 45 |
| Education | $12.42 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $1,977.00 | 1 |
| Gilead Sciences, Inc. | $113.30 | 7 |
| Acerta Pharma LLC | $94.32 | 4 |
| DAVOL INC. | $92.38 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $78.74 | 3 |
| Incyte Corporation | $61.44 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $54.75 | 2 |
| E.R. Squibb & Sons, L.L.C. | $49.61 | 3 |
| Janssen Biotech, Inc. | $40.63 | 2 |
| ARRAY BIOPHARMA INC | $40.40 | 2 |
| BeOne Medicines USA, Inc. | $35.92 | 2 |
| EMD Serono, Inc. | $32.13 | 1 |
| Tempus AI, Inc | $28.57 | 1 |
| SpringWorks Therapeutics, Inc. | $28.25 | 1 |
| PharmaEssentia USA Corporation | $28.05 | 1 |
| Adaptive Biotechnologies Corporation | $27.28 | 1 |
| Iovance Biotherapeutics, Inc. | $26.54 | 1 |
| Agios Pharmaceuticals, Inc. | $26.12 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $25.55 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.64 | 1 |
| Genentech USA, Inc. | $24.17 | 1 |
| Merck Sharp & Dohme Corporation | $22.11 | 1 |
| ADC THERAPEUTICS AMERICA, INC. | $19.82 | 1 |
| ABBVIE INC. | $19.25 | 1 |
| GlaxoSmithKline, LLC. | $18.64 | 1 |
| TerSera Therapeutics LLC | $16.06 | 1 |
| EISAI INC. | $15.39 | 1 |
| Kite Pharma, Inc. | $15.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (47)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.